D
블루엠텍
439580KOSDAQ기타 전문 도매업34.5 / 100
Reference Date: 2026-04-13
Financial Score7.0 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Declined 12.0% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
BlueEmtek operates pharmaceutical distribution platforms such as BluePharmKorea and KoolPharm, selling specialized medications to hospitals and pharmacies. The company also provides the online order management system 'BOS' and cold chain logistics solutions to enhance pharmaceutical distribution efficiency, and operates a medical staffing platform called BlueDoc.
Number of Employees
98people
Average Salary
48.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.634.0Point
PBR
2.49Industry Average 0.630.0Point
4.0x industry avg (risky)
ROE
-9.81Industry Average 2.090.0Point
Well below industry avg
Debt Ratio
20.30Industry Average 7.870.0Point
2.6x industry avg (risky)
Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲28.3% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼270.9% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -10.1% (improving, 3yr)
Detailed News Sentiment
1 totalPositive 0Neutral 0Negative 0
- Neutral
Detailed Momentum
52-week position1.0Point
Near 52w low (1%, downtrend)
Current 3,295Won52-week high 8,41052-week low 3,230
1-month return1.0Point
1m -12.02% (falling)
Volume trend3.0Point
Volume flat
Detailed Disclosure
6 totalPositive 0Neutral 6Negative 0
- Neutral[기재정정]사업보고서 (2025.12)2026-04-03
- Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
- Neutral감사보고서제출2026-03-23
- Neutral사업보고서 (2025.12)2026-03-23
- Neutral의결권대리행사권유참고서류2026-03-17